Scand J Gastroenterol 29(sup204):115
Toxic solvent residues DMF (dimethylformamide) Known liver toxin Associated with reproductive toxicity Must be removed to extremely low limits in GMP drugs DCM (dichloromethane / methylene chloride) Probable human carcinogen Central nervous system depressant Dangerous even in small amounts if injected TFA (trifluoroacetic acid) Corrosive Can remain in peptides as unmeasured TFA salt Pharmaceutical products often convert TFA salts to safer counterions Without validated HPLC, mass spectrometry, and residual solvent testing, patients may be injected with harmful chemical contaminants
Start with the pattern
Not for human consumption, injection, or therapeutic use
The July 2026 Milestone: To formally add this highly sought-after batch of peptides (including BPC-157, TB-500, KPV, MOTS-c, Semax, and Epitalon) back onto the authorised 503A Bulk Substances List, the FDA has set up a crucial Pharmacy Compounding Advisory Committee meeting for July 2324, 2026